The Board of Directors resolved to convene
the 2022 Annual Shareholders' Meeting
Date of events
2022/03/17
To which item it meets
paragraph 17
Statement
1.Date of the board of directors resolution:2022/03/17
2.General shareholders' meeting date:2022/06/15
3.General shareholders' meeting location:
6F.-5, No.28, Ln. 78, Xing'ai Rd., Neihu Dist., Taipei City 114, Taiwan
4.Shareholders meeting will be held by means of (physical shareholders
meeting/ visual communication assisted shareholders meeting /
visual communication shareholders meeting):physical shareholders meeting
5.Cause for convening the meeting I.Reported matters:
(1) 2021 Annual Business Report
(2) Audit Committee's 2021 Review Report
(3) The Distribution of Employees, Directors Remuneration for 2021
6.Cause for convening the meeting II.Acknowledged matters:
(1) Adoption of 2021 Annual Business Report and Financial Statements
(2) Adoption of the Proposal for the Distribution of 2021 Profits
7.Cause for convening the meeting III.Matters for Discussion:
(1)Amendment to the Company's Articles of Incorporation
(2)Amendment to the Operational Procedures for Acquisition and Disposal
of Assets
(3)Amendment to the Rules of Procedure for Shareholders Meetings
(4)Proposal for a cash offering by private placement
8.Cause for convening the meeting IV.Election matters:None
9.Cause for convening the meeting V.Other Proposals:None
10.Cause for convening the meeting VI.Extemporary Motions:None
11.Book closure starting date:2022/04/17
12.Book closure ending date:2022/06/15
13.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
Genetics Generation Advancement Corporation published this content on 17 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 March 2022 13:00:02 UTC.
Genetics Generation Advancement Corp is a Taiwan-based company principally engaged in genetic testing business. The Company mainly provides genetic testing, molecular diagnostics, biotechnology, personalized medical related testing, biological information and health care services. The Company mainly serves in the areas of maternal-fetal precision, pediatric disease diagnosis, drug-associated diagnosis, non-invasive cancer detection and precision health management. The Company operates its businesses in domestic market and overseas markets.
GENETICS GENERATION ADVANCEMENT CORP. 
